MRD May Predict Relapse in NSCLC.
Sign Up to like & getrecommendations! Published in 2020 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-nd2020-010
Abstract: Circulating tumor DNA (ctDNA) may be a useful biomarker for minimal residual disease (MRD) in patients with early-stage non-small cell lung cancer-and MRD may be a good predictor of relapse. In the TRACERx study, a… read more here.
Keywords: mrd may; predict relapse; mrd; may predict ... See more keywords